News
A Fierce Pharma Marketing review of the LinkedIn and Instagram pages of the 20 largest pharmas found that, as of Thursday, ...
Unites Pharma Marketing, PR & Communications, New Product Planning & Commercialization, and Medical Affairs Communities; ...
Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and ...
Mumbai: Sun Pharma has announced the appointment of Richard Ascroft as the new North America (NAM) Chief Executive Officer ...
Galapagos named former Horizon Therapeutics exec Aaron Cox as CFO. Saatchi & Saatchi Wellness, a 2025 MM+M Agency 100 honoree, named Brendan Gallagher as president, Beth Bour as chief client officer ...
Takeda-backed INTERCEPT trial aims to validate biomarkers that could identify people at risk of Crohn's and see if treatment can prevent symptoms developing. ... BlueSky linkedin youtube rss. Sign in.
Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker. ... BlueSky linkedin youtube rss. User account menu.
Global pharma major Lupin Limited (Lupin) announced the launch of prucalopride tablets, 1 mg, and 2 mg, in the United States, following the recent approval of its Abbreviated New Drug Application ...
Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for prucalopride ...
Isaralgagene civaparvovec is a “potential best-in-class gene therapy for Fabry disease,” according to analysts at H.C.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results